The July 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 16, Issue 3
Increasing clarity (free full-text)
Yali Friedman
Personalized medicine and oncology: A commentary and key questions
Robert Freeman
Market access – An essential investment before drug launch
Sean McGrath
Rethinking commercial strategy – A patient-centered commercial model
Sanjay K Rao
Pathways to biomedical tipping points: Vertical, horizontal or other?
Mark J Ahn, Anne S York and Polly Rizova
Key drivers influencing the commercialization of ethanol-based biorefineries
Anuj K Chandel, Om V Singh, Gajula Chandrasekhar, Linga Venkateswar Rao and Mangamoori Lakshmi Narasu
Made in India: Are you ready for outsourced contract manufacturing?
Andrew Lees and Sheila Khatri
Controlling costs in patent litigation
Catherine Rajwani
Book Review: Biotechnology: A Comprehensive Training Guide for the Biotechnology Industry
James Harber
Gene patent considered by English Court of Appeal
Philip Webber
Commentary regarding decision in Myriad Genetics on ‘isolated’ DNA claims
Thomas J Kowalski and Deborah L Lu

![[Bloglines]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/bloglines.png)
![[del.icio.us]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/digg.png)
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)








































